Compound information
- Natural Products
- ZC137656
- Molecular Formula
- C14H21N3O3
- Molecular Weight
- 279.158291532 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-5-amino-1-carbamoyl-pentyl]carbamate
- InChI
- InChI=1S/C14H21N3O3/c15-9-5-4-8-12(13(16)18)17-14(19)20-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10,15H2,(H2,16,18)(H,17,19)/t12-/m0/s1
- InChI Key
- YVKFETNYOZKEGT-LBPRGKRZSA-N
- SMILES
- NCCCC[C@H](NC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000002561188
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 107.44 Å2 | LogP | 0.731 |
LogS | -1.33 | LogD | 0.814 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.931 |
HIA | 0.552 | F20 % | 0.989 |
F30 % | 0.091 | Caco-2 | -5.462 |
MDCK | -5.578 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.978 | PPB | 56.452 |
VD | 1.062 | Fu | 0.07 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.047 | CYP1A2 substrate | 0.769 |
CYP2A6 substrate | 0.585 | CYP2B6 substrate | 0.575 |
CYP2C19 inhibitor | 0.12 | CYP2C19 substrate | 0.864 |
CYP2C8 substrate | 0.762 | CYP2C9 inhibitor | 0.053 |
CYP2C9 substrate | 0.91 | CYP2D6 inhibitor | 0.007 |
CYP2D6 substrate | 0.845 | CYP2E1 substrate | 0.413 |
CYP3A4 inhibitor | 0.028 | CYP3A4 substrate | 0.945 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.676 | CL | 4.345 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.024 | Hepatotoxicity | 0.072 |
Mutagenicity | 0.094 | Rat Oral Acute Toxicity | 0.107 |
FDAMDD | 0.088 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.031 | Eye Corrosion | 0.005 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.022 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.434 | IGC50 | 2.519 |
LC50FM | 3.093 | LC50DM | 5.287 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.138 | NR-AR-LBD | 0.185 |
NR-AhR | 0.003 | NR-Aromatase | 0.053 |
NR-ER | 0.251 | NR-ER-LBD | 0.344 |
NR-PPAR-gamma | 0.276 | SR-ARE | 0.047 |
SR-ATAD5 | 0.367 | SR-HSE | 0.149 |
SR-MMP | 0.01 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.